Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Pulmaquin, Liposomal ciprofloxacin (ARD-3150)
print preview
bookmark
share with colleague
General Information
Company
Aradigm Corp.
Description
Dual release product consisting of liposomal-encapsulated form of ciprofloxacin, a DNA gyrase inhibitor, mixed with a solution of free ciprofloxacin for inhalation
Molecular Target
DNA gyrase
Mechanism of Action
Prokaryotic replication inhibitor
Latest Stage of Development
Phase III
Indication
Chronic obstructive pulmonary disease (COPD)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information